Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers Squibb Medical Dialogues Bureau11 April 2020 8:26 AM GMT USA: A federal judge increased to $1.2 billion the damages that Gilead Sciences Inc must pay to Bristol-Myers Squibb Co in a patent infringement...
Merck loses bid to revive over Rs 18 crore patent verdict against Gilead Farhat Nasim31 Oct 2019 9:57 AM GMTIn 2016, a jury returned a verdict that Gilead Science's hepatitis C drugs Sovaldi and Harvoni infringed the patent, which Merck acquired when it...
Fight for Vildagliptin: Natco goes to court against Novartis Farhat Nasim7 Sep 2019 11:02 AM GMTMumbai: Throwing an indirect challenge at patent holder Novartis, drugmaker Natco Pharma has submitted a fresh application in a Hyderabad court...
Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib Farhat Nasim1 Sep 2019 9:03 AM GMTNew Delhi: In a major relief to Natco, the Delhi High Court has lifted a ban on Natco Pharma from manufacturing fresh stock of on-small cell lung...
Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors Farhat Nasim30 July 2019 8:38 AM GMTNew Delhi: The patent protection of blockbuster anti-diabetic drug Vildagliptin manufactured by the Swiss drugmaker, Novartis, will soon expire on...
Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets Meghna A Singhania22 April 2019 8:37 AM GMTAHMEDABAD: In a major setback, three Gujarat based pharmaceutical companies including Cadila Healthcare, West Coast Pharmaceutical Works Ltd and Maan...
Suven Life Sciences gets US court nod to buy assets of Rising Pharmaceuticals Farhat Nasim14 April 2019 4:30 AM GMT"This court approval brings closure to the sale process for Rising Pharmaceuticals and paves the way for a seamless transition of the portfolio,...
Suven Life Sciences secures Product Patent in Brazil, Eurasia Garima29 March 2019 4:10 AM GMTThe granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative...
US court upholds dismissal of 200 million dollars Merck verdict against Gilead Ruby Khatun Khatun27 April 2018 4:00 AM GMTA U.S. appeals court affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a...
Gilead wins reversal of 2.54 billion dollars hepatitis C drug patent verdict Ruby Khatun Khatun19 Feb 2018 4:15 AM GMTA federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs...
Illumina wins 26.7 million dollars in patent fight with Roche unit Ariosa Medical Dialogues Bureau28 Jan 2018 4:00 AM GMTGene testing company Illumina won a $26.7 million jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a subsidiary of Roche Holdings AG,...
France fines Johnson and Johnson 29.6 million dollars over painkiller patch Ruby Khatun Khatun21 Dec 2017 4:45 AM GMTPARIS: France's competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.6 million) on Wednesday after it ruled...
